GET DAILY SIGNALSJBS Reports Q3 2026 Results with -70.7% Net Income Decline
Key Takeaways
- JBS reported third-quarter 2026 net sales of $22.7 billion, up roughly 0.6% from the prior-year period but below consensus estimates.
- Net income fell to $188.9 million, a decline of about 70.7% year over year, with earnings per share of $0.15 versus $0.52 a year earlier.
- Adjusted EBITDA under IFRS dropped 35.6% to $1.18 billion, as weaker beef and pork conditions weighed on profitability.
- Adjusted earnings per share of $0.16 missed the analyst consensus of $0.32, and shares fell about 7% in after-hours trading following the release.
- Free cash flow turned negative at $167 million, while net leverage rose to 3.54x from 2.39x a year earlier.
Earnings Context and Why It Matters
JBS S.A. is one of the world's largest protein producers, operating across beef, pork, poultry, and value-added foods in multiple geographies, including North America, Brazil, Australia, and Europe. Its third-quarter report offers investors a broad read on global meat demand, livestock supply cycles, and consumer pricing power. The company entered the quarter following a record second-quarter revenue performance but with persistent pressure in its U.S. beef business. This results release matters because it reveals whether JBS's diversified portfolio can offset weakness in any single protein or region, and because it signals how management is balancing profitability against rising leverage and tighter free cash flow amid a more challenging operating environment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Reported Results
For the third quarter of 2026, JBS reported net sales of $22.7 billion, a modest 0.6% increase from $22.6 billion in the prior-year quarter but below the roughly $23.6 billion analysts had anticipated. Net income attributable to shareholders was $164.4 million, down 71.7% from $580.9 million a year earlier, while total net income came in at $188.9 million.
Earnings per share were $0.15, compared with $0.52 in the third quarter of 2025. On an adjusted basis, earnings per share of $0.16 fell short of the consensus estimate of $0.32 by approximately half. Consolidated adjusted EBITDA under IFRS declined 35.6% to $1.18 billion, and the EBITDA margin narrowed from 8.1% to 5.2%.
Results were mixed across the portfolio. JBS Beef North America returned to positive adjusted EBITDA under U.S. GAAP, while Pilgrim's Pride, JBS Brazil, and JBS USA Pork each posted significant year-over-year declines in adjusted EBITDA. Free cash flow was negative $167 million, and net leverage ended the quarter at 3.54x.
Market Reaction and Investor Sentiment
The market responded negatively to the third-quarter results, with JBS shares falling about 7% in after-hours trading after adjusted earnings per share missed consensus by roughly 50% and revenue came in below estimates. Investors appeared to focus on the sharp compression in adjusted EBITDA margins, the negative free cash flow, and the increase in net leverage to 3.54x. Sentiment was further tempered by weaker exports to China following the completion of the 2026 quota, which pressured JBS Brazil's profitability. The improvement in the North American beef segment was a relative bright spot, but it was not enough to offset broader softness across pork and poultry markets.
Forward Outlook and Key Factors to Monitor
Following this earnings event, investors will be watching whether JBS can stabilize profitability across its most challenged segments. The North American beef business showed sequential improvement during the quarter, and management noted that margins progressed from negative territory in July to positive levels by September. Sustaining that momentum will be an important signal for the coming quarters.
Leverage and cash flow will remain central themes. Net leverage climbed to 3.54x, above the company's long-term target range, and free cash flow turned negative. Management has emphasized execution, cash generation, and debt reduction as priorities, so investors will monitor whether working capital management and disciplined capital allocation begin to ease balance-sheet pressure.
Demand dynamics in China are another key factor. JBS noted that Chinese buyers began securing volumes for the 2027 quota early in the fourth quarter, which could support export volumes for JBS Brazil. Meanwhile, global pork supply and softer domestic demand weighed on JBS USA Pork, and investors will look for signs of stabilization. Input costs, cattle availability, and currency movements remain variables that could influence margins across regions in the quarters ahead.
Exploring AI Tools in My Research Process
In my view, tools like Tickeron’s AI Screener can add useful context when reviewing earnings across the protein sector. I use it to quickly filter peers by fundamentals, technical patterns, and recent performance, which helps me cross-check how JBS stacks up against comparable names without spending hours on manual work. It is one way I stay organized when following these kinds of quarterly updates.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
JBS in -3.70% downward trend, falling for three consecutive days on November 06, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where JBS declined for three days, in 204 of 281 cases, the price declined further within the following month. The odds of a continued downward trend are 73%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
JBS broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for JBS entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on JBS as a result. In 66 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for JBS just turned positive on November 04, 2026. Looking at past instances where JBS's MACD turned positive, the stock continued to rise in 32 of 43 cases over the following month. The odds of a continued upward trend are 74%.
JBS moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for JBS crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 46%.
Following a +5.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where JBS advanced for three days, in 202 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.992) is normal, around the industry mean (6.914). P/E Ratio (11.664) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (8.458). JBS's Dividend Yield (0.321) is considerably higher than the industry average of (0.049). P/S Ratio (0.441) is also within normal values, averaging (5.003).
The Tickeron Seasonality Score of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. JBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JBS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry FoodMajorDiversified
Advertisement